Literature DB >> 8843238

Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans.

S Gujral1, E Brummer, D A Stevens.   

Abstract

Possible enhanced candidacidal synergy of fluconazole and human monocyte-derived macrophages by extended culture time was studied. Synergistic candidacidal activity increased from 1 day to 3 days and was maximal at 6 days. Enhanced synergistic candidacidal activity at 144 h was observed over a 10-fold challenge dose range. Enhanced synergy with culture time was seen with fluconazole-susceptible and -resistant isolates of Candida albicans. These findings emphasize the importance of dosage and an adequate period of therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843238     DOI: 10.1093/infdis/174.4.888

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Authors:  S Vora; N Purimetla; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.

Authors:  U Natarajan; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Authors:  S Vora; S Chauhan; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells.

Authors:  L Pitzurra; R Fringuelli; S Perito; F Schiaffella; R Barluzzi; F Bistoni; A Vecchiarelli
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

Authors:  A L Baltch; R P Smith; M A Franke; W J Ritz; P B Michelsen; L H Bopp
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.

Authors:  Peter G Sohnle; Beth L Hahn
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.

Authors:  Michael R Yeaman; Darwin Cheng; Bhavesh Desai; Leon I Kupferwasser; Yan-Qiong Xiong; Kimberly D Gank; John E Edwards; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.

Authors:  Mahomed-Yunus S Moosa; Jack D Sobel; Hussain Elhalis; Wenjin Du; Robert A Akins
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.